tiprankstipranks
Trending News
More News >
Qyuns Therapeutics Co., Ltd. Class H (HK:2509)
:2509
Hong Kong Market

Qyuns Therapeutics Co., Ltd. Class H (2509) Financial Statements

Compare
0 Followers

Qyuns Therapeutics Co., Ltd. Class H Financial Overview

Qyuns Therapeutics Co., Ltd. Class H's market cap is currently ―. The company's EPS TTM is HK$-1.658; its P/E ratio is ―; Qyuns Therapeutics Co., Ltd. Class H is scheduled to report earnings on ―, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 14.75M¥ 9.66M¥ 21.35M
Gross Profit¥ 14.75M¥ -25.85M¥ -9.56M
Operating Income¥ -504.51M¥ -388.19M¥ -241.87M
EBITDA¥ -484.12M¥ -275.05M¥ -149.46M
Net Income¥ -507.75M¥ -346.76M¥ -359.48M
Balance Sheet
Cash & Short-Term Investments¥ 377.25M¥ 689.57M¥ 758.96M
Total Assets¥ 795.58M¥ 1.16B¥ 1.31B
Total Debt¥ 346.06M¥ 331.49M¥ 355.07M
Net Debt¥ 129.76M¥ 92.25M¥ 88.33M
Total Liabilities¥ 494.63M¥ 419.55M¥ 444.45M
Stockholders' Equity¥ 324.54M¥ 720.48M¥ 820.02M
Cash Flow
Free Cash Flow¥ -308.63M¥ -301.70M¥ -228.64M
Operating Cash Flow¥ -300.68M¥ -275.23M¥ -157.60M
Investing Cash Flow¥ 243.11M¥ -11.20M¥ -306.69M
Financing Cash Flow¥ 61.21M¥ 263.84M¥ 357.63M
Currency in CNY

Qyuns Therapeutics Co., Ltd. Class H Earnings and Revenue History

Qyuns Therapeutics Co., Ltd. Class H Debt to Assets

Qyuns Therapeutics Co., Ltd. Class H Cash Flow

Qyuns Therapeutics Co., Ltd. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis